Клинический выбор Планы, виды, алгоритмы лечения и диагностики
treatment for preterm birth risk. Microbiome. 2017; 5(1): 6. DOI: 10.1186/s40168–016–0223–9. 11. Romero R., Conde-Agudelo A., El-Refaie W. et al. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound. Obstetrics Gynecol. DOI: 10.1002/uog.17397. 12. Ходжаева З.С., Дембовская С.В., Доброхотова Ю.Э., Сичинава Л.Г. Медикаментозная профилактика преждевременных родов (результаты международного многоцентрового открытого исследования МИСТЕРИ). Акушерство и гинекология 2016; (8). 13. Микронизированный прогестерон в терапии невынашивания беременности. Заключение Рабочего совещания группы экспертов в рамках регионального форума «Мать и Дитя», 28 июня 2017 г. https://doi.org/10.17116/repro201723319–31). 14. Saccone G., Khalifeh A., Elimian A. et al. Vaginal progesterone compared to intramuscular 17‑alphahydroxyprogesteronecaproate for prevention of recurrent spontaneous preterm birth in singleton gestations: a systematic review and meta-analysis of randomized controlled trials. Ultrasound. Obstet. Gynecol. 2017; 49: 315–21. 15. Gyamfi-Bannerman C., Gilbert S., Landon M.B. et al. Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm. Birth. Obstet. Gynecol. 2013; 119: 555–9. 16. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice Society for Maternal-Fetal Medicine Publications Committee, with the assistance of Vincenzo Berghella, MD. Am. J. Obstetrics Gynecol. 2013; 376–86. 17. Levin H.I., Ananth C.V., Benjamin-Boamah C. et al. Clinical indication and timing of antenatal corticosteroid administration at a single centre. BJOG 2016; 123(3): 409–14. 18. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of pretermbirth. Cochrane Database of Systematic Reviews 2017; 3: CD004454. DOI: 10.1002/14651858.CD004454.pub3. 19. World Health Organization recommendations on interventions to improve preterm birth outcomes, Geneva, 2015. PMID: 26447264. 20. American College of Obstetricians and Gynecologists. Management of Preterm Labor. Practice bulletin Number 159, 2016. 21. Тетруашвили Н.К., Агаджанова А.А., Милушева А.К. Истмикоцервикальная недостаточность с пролабированием плодного пузыря: новые возможности терапии. Акушерство и гинекология 2015; (9): 106–9. 22. Dodd Jodie M., Crowther Caroline A., Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews 2012; 12: CD003927. DOI: 10.1002/14651858. CD003927.pub3. 23. Neilson J.P., West H.M., Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2014; 2: CD004352. DOI: 10.1002/14651858.C D004352.pub3. 24. Driul L., Londero A.P., Adorati-Menegato A. et al. Therapy side effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour. J. Obstet. Gynaecol. 2014; 34: 684–9. 25. Баев О.Р., Васильченко О.Н., Карапетян А.О. и др. Сравнение токолиза гексопреналином и атозибаном. Медицинский Совет 2017; (2): 57–61. 26. Van Vliet E.O.G., Nijman T.A.J., Schuit E. et al. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre randomized controlled trial. Lancet. 2016; http://dx.doi. org/10.1016/S0140–6736(16)00548–1. 27. Flenady V., Reinebrant H.E., Liley H.G. et al. Oxytocin receptor antagonists for inhibiting preterm labour. V. Cochrane Database of
76 ❘
МЕДИЦИНСКИЙ
ОППОНЕНТ ❘
№2 АВГУСТ 2018
Systematic Reviews. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd, 2014. 28. Jorgensen J.S., Weile L.K., Lamont R.F. Preterm labor: current tocolytic options for the treatment of preterm labor. Expert. Opin. Pharmacother. 2014; 15(5): 585–8. 29. Doyle L.W., Crowther C.A., Middleton P. et al. Magnesiumsulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009; (1): CD004661. 30. Alfirevic Z., Stampalija T., Roberts D., Jorgensen A.L. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database of Systematic Reviews 2012; 4: CD008991. 31. Berghella V., Odibo A., To M.S. et al. Cerclage for short cervix on ultrasonog-raphy; meta-analysis of trials using individual patient data. Obstet. Gynecol. 2005; 106; 181–9. 32. Khodzhaeva Z., Sukhikh G. Experience with cervical serclage in multiple pregnancies. J Maternal. Fetal. Neоnatal. Medicine. 2009; 21. 33. Goya M., Pratcorona L., Merced C. et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet. 2012; 379: 1800–6. 34. Saccone G., Ciardulli A., Xodo S. et al. Cervical pessary for preventing preterm birth in twin pregnancies with short cervical length: a systematic review and meta-analysis. J Maternal. Fetal. Neonatal. Medicine. 2017; 30(24): 2918–25. DOI: 10.1080/14767058.2016.1268595. 35. Yüce T., Konuralp B., Kalafat E., Söylemez F. Pessary use in pregnant women with short cervix. J. Turk. Ger. Gynecol. Assoc. 2016; 17: 120–2. 36. Xin-Hang Jin, Dan Li, Li-Li Huang. Cervical pessary for prevention of preterm birth: a meta-analysis. Published online 2017, Feb 17. DOI: 10.1038/srep42560. 37. Zork N., Biggio J., Tita A. et al. Decreasing prematurity in twin gestations: predicaments and possibilities. Obstet. Gynecol. 2013; 122(2 Pt 1): 375–9. 38. Rundell K., Panchal B. Preterm Labor: Prevention and Management. Am. Fam. Physician. 2017; 95(6): 366–72. 39. Kamath-Rayne B.D., DeFranco E.A., Michael M.P. Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation. An evaluation of neonatal outcomes. Obstet. Gynecol. 2012; 119: 909–16. 40. Brocato B., Holliday N., Whitehurst R.M. Jr. et al. Delayed cord clamping in preterm neonates: a review of benefits and risks. Obstet. Gynecol. Survey. 2016; 71: 39–42. Вклад авторов. З.С. Ходжаева, Г.Э. Гусейнова, К.А. Горина: разработка дизайна исследования, получение данных для анализа, обзор публикаций по теме статьи, статистический анализ полученных данных, написание текста рукописи. Authors’ contributions. Z.S. Khodzhaeva, G.E. Guseynova, K.A. Gorina: developing of research design, obtaining data for analysis, reviewing publications on the topic of the article, statistical analysis of the obtained data, article writing. Конфликт интересов. Авторы заявляют об отсутствии конфликта интересов. Conflict of interest. The authors declare no conflict of interest. Финансирование. Исследование проведено без спонсорской поддержки. Financing. The study was performed without external funding. Статья поступила: 10.06.2018. Принята к публикации: 09.07.2018. Article received: 10.06.2018. Accepted for publication: 09.07.2018.